RxDoctor Payments Data

Miranda Elliott, APRN

Psychiatric/Mental Health · Corbin, KYNPI 1487177242

Payments from drug & device makers

$3,730in general payments, 2019–2025

Across 224 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$733
  • AbbVie$447
  • Otsuka America Pharmaceutical, Inc.$439
  • Teva Pharmaceuticals USA, Inc.$375
  • Johnson & Johnson$362
  • Alkermes, Inc.$319
  • plus $1K from 8 others

What the payments were for

  • Food & beverage$3,68399%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,730 in reported general payments places this provider in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$8,826
Medicare patients
49
Services billed
158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole53$84,714
AristadaAripiprazole Lauroxil23$63,129
Abilify MaintenaAripiprazole21$56,610
VraylarCariprazine Hcl28$40,369
CaplytaLumateperone Tosylate24$38,421
Invega SustennaPaliperidone Palmitate20$36,030
TrintellixVortioxetine Hydrobromide55$31,886
LybalviOlanzapine/Samidorphan Malate16$24,462
Asenapine Maleate13$8,968
Chlorpromazine Hcl19$7,161
Aripiprazole104$5,651
LexaproEscitalopram Oxalate11$4,961
Fluvoxamine Maleate55$3,355
Olanzapine190$3,168
Lurasidone Hcl27$2,829

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$439$141,32474 claims
Alkermes, Inc.Aristada, Lybalvi$319$87,59239 claims
AbbVieVraylar, Lexapro$447$45,33039 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$265$38,42124 claims
Johnson & JohnsonInvega Sustenna$362$36,03020 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$120$31,88655 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →